Adcock Richard
Insider CIK 1830328 · NK Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-22 | 2026-02-24 | 152,439 | — | $0 | 152,439 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-22 | 2026-02-24 | 77,560 | $8.70 | $674.8K | 560,344 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-22 | 2026-02-24 | 152,439 | — | $0 | 637,904 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-10 | 2026-02-12 | 274,122 | — | $0 | 548,246 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-10 | 2026-02-12 | 140,048 | $6.93 | $970.5K | 485,465 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-10 | 2026-02-12 | 274,122 | — | $0 | 625,513 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 34,483 | — | $0 | 51,731 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 34,483 | — | $0 | 368,901 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 17,510 | $1.98 | $34.7K | 351,391 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-02-22 | 2025-02-25 | 152,439 | — | $0 | 304,878 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2025-02-22 | 2025-02-25 | 78,167 | $3.42 | $267.3K | 334,418 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-02-22 | 2025-02-25 | 152,439 | — | $0 | 412,585 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2025-02-10 | 2025-02-12 | 2,812,500 | — | $0 | 2,812,500 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2025-02-10 | 2025-02-12 | 822,368 | — | $0 | 822,368 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 34,483 | — | $0 | 86,214 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2024-12-31 | 2025-01-03 | 17,475 | $2.56 | $44.7K | 260,146 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 34,483 | — | $0 | 277,621 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 1,591,463 | — | $0 | 1,591,463 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 457,317 | — | $0 | 457,317 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2024-02-05 | 2024-02-06 | 83,334 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2024-02-05 | 2024-02-06 | 83,334 | — | $0 | 286,303 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2024-02-05 | 2024-02-06 | 43,165 | $4.04 | $174.4K | 243,138 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2023-12-31 | 2024-01-03 | 34,483 | — | $0 | 120,697 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2023-12-31 | 2024-01-03 | 17,096 | $5.02 | $85.8K | 202,969 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2023-12-31 | 2024-01-03 | 34,483 | — | $0 | 220,065 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2023-02-05 | 2023-02-07 | 83,333 | — | $0 | 83,334 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2023-02-05 | 2023-02-07 | 42,192 | $4.33 | $182.7K | 185,582 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2023-02-05 | 2023-02-07 | 83,333 | — | $0 | 227,774 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2022-12-31 | 2023-01-04 | 8,620 | — | $0 | 155,180 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2022-12-31 | 2023-01-04 | 8,620 | — | $0 | 148,714 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2022-12-31 | 2023-01-04 | 4,273 | $5.07 | $21.7K | 144,441 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2022-03-23 | 2022-03-25 | 350,000 | — | $0 | 350,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2022-03-23 | 2022-03-25 | 350,000 | — | $0 | 350,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2022-02-05 | 2022-02-08 | 83,333 | — | $0 | 166,667 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2022-02-05 | 2022-02-08 | 29,415 | $5.39 | $158.5K | 140,094 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2022-02-05 | 2022-02-08 | 83,333 | — | $0 | 169,509 | SEC↗ |
| IBRX ImmunityBio, Inc. | P Buy | 2021-10-08 | 2021-10-08 | 7 | $9.00 | $63 | 7 | SEC↗ |
| IBRX ImmunityBio, Inc. | P Buy | 2021-10-08 | 2021-10-08 | 1,923 | $8.81 | $16.9K | 1,930 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2021-09-09 | 2021-09-13 | 8,620 | — | $0 | 163,800 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2021-09-09 | 2021-09-13 | 4,273 | $9.95 | $42.5K | 86,176 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2021-09-09 | 2021-09-13 | 8,620 | — | $0 | 90,449 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2021-03-09 | 2021-04-14 | 172,420 | — | $0 | 172,420 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 750,000 | — | $0 | 750,000 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2021-02-05 | 2021-02-09 | 150,000 | — | $0 | 0 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2021-02-05 | 2021-02-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NK NantKwest, Inc. | F Tax w/h | 2021-02-05 | 2021-02-09 | 68,171 | $23.72 | $1.62M | 81,829 | SEC↗ |